Background Invasive mucinous adenocarcinoma (IMA) comprises~ 5% of lung
adenocarcinoma. There is no effective therapy for IMA when surgical resection is not …

8037 Background: Invasive mucinous adenocarcinoma (IMA), accounting for 2–10% of lung
adenocarcinomas, often mimics pneumonia with multicentric opacities in multiple lobes and …

Though invasive mucinous adenocarcinoma of the lung (IMA) is pathologically distinctive,
the molecular mechanism driving IMA is not well understood, which hampers efforts to …

Purpose: Invasive mucinous adenocarcinoma (IMA) is a unique subtype of lung
adenocarcinoma, characterized genomically by frequent KRAS mutations or specific gene …

Background We performed an analysis to clarify differences in clinicopathological and
molecular features of lung invasive mucinous adenocarcinoma (IMA) based on computed …

Purpose We performed this analysis to distinguish the differences in two subtypes of lung
invasive mucinous adenocarcinoma (IMA) with different kinds of morphological …

Introduction Invasive mucinous lung adenocarcinoma (IMA) has unique radiological findings
and pathological characteristics. IMA is classified into solitary and pneumonic types; …

Background Invasive mucinous adenocarcinoma (IMA) of the lung is a distinct histological
subtype with unique clinical and pathological features. Despite previous genomic studies on …

Introduction: Invasive mucinous lung adenocarcinoma (IMA) has unique radiological
findings and pathological characteristics. IMA is classified into solitary and pneumonic types; …

Invasive mucinous adenocarcinoma (IMA) is defined by the WHO classification as a primary
lung adenocarcinoma with tumor cells showing goblet cell-or columnar cell-morphology …